Abstract
An enzyme immunoassay kit that detects serum IgA antibody reacting to glycopeptidolipid core antigen derived from Mycobacterium avium complex (MAC) was not useful for differentiating MAC pulmonary disease (PD) from Mycobacterium abscessus complex PD (MAB-PD). However, this assay could be useful for differentiating MAC- and MAB-PD from pulmonary tuberculosis. (This study has been registered at ClinicalTrials.gov under registration no. NCT00970801.)
| Original language | English |
|---|---|
| Pages (from-to) | 2747-2749 |
| Number of pages | 3 |
| Journal | Journal of Clinical Microbiology |
| Volume | 51 |
| Issue number | 8 |
| DOIs | |
| Publication status | Published - 2013 Aug 1 |
All Science Journal Classification (ASJC) codes
- Microbiology (medical)
Fingerprint Dive into the research topics of 'Serodiagnosis of Mycobacterium avium complex and Mycobacterium abscessus complex pulmonary disease by use of IgA antibodies to glycopeptidolipid core antigen'. Together they form a unique fingerprint.
Cite this
Jeong, B. H., Kim, S. Y., Jeon, K., Lee, S. Y., Shin, S. J., & Koh, W. J. (2013). Serodiagnosis of Mycobacterium avium complex and Mycobacterium abscessus complex pulmonary disease by use of IgA antibodies to glycopeptidolipid core antigen. Journal of Clinical Microbiology, 51(8), 2747-2749. https://doi.org/10.1128/JCM.00702-13